Efficacy, tissue distribution, and residue depletion of oxytetracycline in WS-RLP infected California red abalone Haliotis rufescens

Aquaculture

Volumn 277, Issue 3-4, 2008, Pages 138-148

  Rosenblum, E S ^a   Robbins, T T ^b   Scott, B B ^c   Nelson, S ^c   Juhasz, C ^b   Craigmill, A ^a   Tjeerdema, R S ^a   Moore, J D ^b   Friedman, C S ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA DAVIS   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Abalone; Oxytetracycline; Pathogen re challenge; Pharmacokinetics; Rickettsia; Withering syndrome

Indexed keywords

ARTIFICIAL DIET; BACTERIAL DISEASE; CONCENTRATION (COMPOSITION); DISEASE TREATMENT; DRUG; EFFICIENCY MEASUREMENT; GASTROPOD; MODELING; PHYSIOLOGICAL RESPONSE; TEMPERATURE EFFECT;

HALIOTIDAE; HALIOTIS RUFESCENS; PROKARYOTA; RICKETTSIA;

EID: 42749093424     PISSN: 00448486     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aquaculture.2008.03.005     Document Type: Article

References (36)

1. Akaike H. A new look at the statistical model identification. IEEE Trans. Automat. Contr. 19 (1974) 716-723
2. Andree K.B., Friedman C.S., Moore J.D., and Hedrick R.P. A polymerase chain reaction for detection of genomic DNA of a Rickettsiales-like prokaryote associated with Withering Syndrome in black abalone (Haliotis cracherodii). J. Shellfish Res. 19 (2000) 213-218
3. Association of Official Analytical Chemists (AOAC). 1990. Official methods of analysis, 15th edition. Association of Analytical Chemists, Inc., Arlington, VA. Pp. 115-118, 126-137.
4. Braid B., Moore J.D., Robbins T.T., Hedrick R.P., Tjeerdema R.S., and Friedman C.S. Health and survival of red abalone, Haliotis rufescens, under varying temperature, food supply and exposure to the agent of withering syndrome. J. Invert. Path. 89 (2005) 219-231
5. Bryan G.W., Potts G.W., and Forster G.R. Heavy metals in the gastropod mollusc Haliotis tuberculata. J. Mar. Biol. Assoc. 57 (1977) 379-390
6. Campbell D.A., Pantazis P., and Kelly M.S. Impact and residence time of oxytetracycline in the sea urchin, Psammechinus miliaris, a potential aquaculture species. Aquaculture 202 (2001) 73-87
7. Chen C.Y., Getchell R.G., Wooster G.A., Craigmill A.L., and Bowser P.R. Oxytetracycline residues in four species of fish after 10-day oral dosing in feed. J. Aquat. Anim. Health 16 (2004) 208-219
8. Chiayvareesajja S., Chandumpai A., Theapparat Y., and Faroongsarng D. The complete analysis of oxytetracycline pharmacokinetics in farmed Pacific white shrimp (Litopenaeus vannamei). J. Vet. Pharm. Ther. 29 5 (2006) 409-414
9. Chorpa I., and Roberts M. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacteria resistance. Microbiol. Mol. Bio. Rev. 65 2 (2001) 232-260
10. Cook E.J., Kelly M.S., and McKenzie J.D. Somatic and gonadal growth of the sea urchin Psammechinus miliaris (Gmelin) fed artificial salmon feed compared with a macroalgal diet. J. Shellfish Res. 17 5 (1998) 1549-1555
11. Doi A.M., and Stoskopf M.K. The kinetics of oxytetracycline degradation in deionized water under varying temperature, pH, light, substrate and organic matter. J. Aquat. Anim. Health 12 (2000) 246-253
12. Edwards S., and Condon C. Digestive protease characterization, localization and adaptation in blacklip abalone (Haliotis rubra Leach). Aquacult. Res. 32 2 (2001) 95-102
13. Forth W., and Rummel W. Iron absorption. Physiol. Rev. 53 (1973) 724-792
14. Friedman C.S., Thomson M., Chun C., Haaker P.L., and Hedrick R.P. Withering syndrome of the black abalone Haliotis cracherodii (Leach): water temperature, food availability, and parasites as possible causes. J. Shellfish Res. 16 (1997) 403-411
15. Friedman C.S., Andree K.B., Beauchamp K.A., Moore J.D., Robbins T.T., Shields J.D., and Hedrick R.L. 'Candidatus Xenohaliotis californiensis', a newly described pathogen of abalone, Haliotis spp., along the west coast of North America. Int. J. Syst. Evol. Microbiol. 50 (2000) 847-855
16. Friedman C.S., Trevelyan G., and Robbins T.T. Devlopment of an oral administration of oxytetracycline to control losses due to withering syndrome in cultured red abalone Haliotis rufescens. Aquaculture 224 (2003) 1-23
17. Gardner G.R., Harshbarger J.C., Lake J., Sawyer T.K., Price K.L., Stephenson M.D., Haaker P.L., and Togstad H.A. Association of prokaryotes with symptomatic appearance of withering syndrome in black abalone Haliotis cracherodii. J. Invert. Path. 66 (1995) 111-120
18. Haaker P.L., Richards D.V., Friedman C.S., Davis G.E., Parker D.O., and Togstad H. Mass mortality and withering syndrome in black abalone Haliotis cracherodii in California. In: Shephard S.A., Tegner M.J., and Guzman del Proo S.A. (Eds). Abalone of the World (1992), Blackwell Scientific, Oxford 214-224
19. Haug T., and Hals P.A. Pharmacokinetics of oxytetracycline in Arctic charr (Salvelinus alpinus) in freshwater at low temperature. Aquaculture 186 (2000) 175-191
20. Hustvedt S.O., Storebakken T., and Salte R. Does oral administration of oxolinic acid or oxytetracycline affect feed intake of rainbow trout?. Aquaculture 92 (1991) 109-113
21. Hyne R.V., Smith J.D., and Ellender G. Tissue and sub-cellular distribution of Fe, Cu, Zn and super(210)Po in the abalone Haliotis rubra. Mar. Biol. 116 1 (1992) 75-80
22. Kusumoto K., Shirahata S., and Kamei Y. Purification and characterization of alpha-d-galactosidase produced by ADG cell line established from abalone digestive gland. Cytotechnology 33 1-3 (2000) 47-52
23. Jobling M. Fish Bioenergetics (1994), Chapman and Hall, London
24. Malvisi J., della Rocca G., Anfossi P., and Giorgetti G. Tissue distribution and residue depletion of oxytetracycline in sea bream (Sparus aurata) and sea bass (Dicentrarchus labrax) after oral administration. Aquaculture 147 (1996) 159-168
25. Martindale The Extra Pharmacopoeia, 31st ed., 1996. Reynolds, J.E.F., ed., Royal Pharmaceutical Society, London, UK, pp. 259-260, 287.
26. Mohney L.L., Williams R.R., Bell T.A., and Lightner D.V. Residues of oxytetracycline in cultured juvenile blue shrimp, Penaeus stylirostris (Crustacea: Decapoda), fed medicated feed for 14 days. Aquaculture 149 (1997) 193-202
27. Moore J.D., Robbins T.T., and Friedman C.S. Withering syndrome in farmed red abalone, Haliotis rufescens: thermal induction and association with a gastrointestinal Rickettsiales-like prokaryote. J. Aquat. Anim. Health 12 (2000) 26-34
28. Moore J.D., Finley C.A., Robbins T.T., and Friedman C.S. Withering syndrome and restoration of Southern California abalone populations. Calif. Coop. Ocean. Fish. Investig. Rep. 43 (2002) 112-117
29. Reed L.A., Siewicki T.C., and Shah J.C. Pharmacokinetics of oxytetracycline in the white shrimp, Litopenaeus setiferus. Aquaculture 232 (2004) 11-28
30. Rigos G., Nengas I., Tyrpenou A.E., Alexis M., and Troisi G.M. Pharmacokinetics and bioavailability of oxytetracycline in gilthead sea bream (Sparus aurata) after a single dose. Aquaculture 221 (2003) 75-83
31. Sheiner L.B., and Beal S.L. Evaluation of methods for estimating population pharmacokinetic parameters. I. Michealis-Menten model: routine clinical data. J. Pharmacokinet. Biopharm. 8 (1980) 553-571
32. Schnick R.A. Approval of drugs and chemicals for use by the aquaculture industry. Vet. Human Tox. 40 Suppl. 2 (1998) 9-19
33. Sommerville D. Black abalone studies. Thermal Effects Monitoring Program. 1990 annual report, Diablo Canyon Power Plant, Pacific Gas & Electric Company, March 1991 vol. 4 (1991) 51-62
34. US FDA Federal Register, 1996. 61 (247), 67453.
35. Vilchis L.I., Tegner M.J., Moore J.D., Friedman C.S., Riser K.L., Robbins T.T., and Dayton P.K. Effects of ocean warming on the growth, reproduction and survivorship of red and green abalones in southern California. Ecol. Appl. 15 2 (2005) 469-480
36. Wang Q., Liu Q., and Li J. Tissue distribution and elimination of oxytetracycline in perch Lateolabras janopicus and black seabream (Sparus macrocephalus) following oral administration. Aquaculture 237 (2004) 31-40